TOWA Pharmaceutical Completes First Tranche Preferred Share Issuance

TOKYO, Jul 31 (Pulse News Wire) – Towa Pharmaceutical CO.,LTD. (4553.T) completed the first tranche issuance of Series A preferred shares.

According to the company's statement, the issuance involved 10,000 Series A preferred shares at a price of ¥1 million per share, raising a total of ¥10.00 billion. This transaction was approved during the 70th Ordinary General Meeting of Shareholders held on June 24, 2026, and subsequently authorized by the board meeting on May 21, 2026.

As a result, the capital stock increased by ¥5 billion and the capital reserve increased by ¥5 billion due to the issuance. Additionally, the company reported a reduction in capital stock and capital reserve amounting to ¥5 billion and ¥5 billion, respectively.

These reductions offset the entire increase in capital stock and capital reserve resulting from the Series A preferred share issuance, which was reallocated to other capital reserves.